1040352-82-6 |
The drug also inhibits the production of reactive oxygen species, which are believed to contribute to inflammation. Acetamidine hydrobromide is a good candidate for treating patients with alzheimer's disease because it has been shown that it can inhibit amyloid-beta aggregation and reduce oxidative stress in neuronal cells.
CAS 1040352-82-6|Acetamidine hydrobromide
|
1040352-82-6 |
|
|
C2H7BrN2 |
|
|
139 |
|
|
414.4±35.0 degree (Predicted) |
|
P 1040352-82-6|Acetamidine hydrobromide
Package:0.1g,1g,5g,25g,100g,500g,1kg
of CAS 1040352-82-6|Acetamidine hydrobromide
Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase
C Maccallini, A Patruno, N Besker, JI Alì… - Journal of medicinal …, 2009 - ACS Publications
… In this paper, we report the synthesis of novel acetamidines structurally related to 1 and the
in … with Et 2 O (2 × 20 mL), and lyophilized to afford the desired acetamidine hydrobromide. …
maq per Qat: cas:1040352-82-6|acetamidine hydrobromide, China cas:1040352-82-6|acetamidine hydrobromide manufacturers, factory
